VERO

Venus Concept Inc. [VERO] Stock Forecast

Q: What is Venus Concept Inc. stock symbol ?

Venus Concept Inc. is a CA stock, located in Toronto of On and trading under the symbol VERO

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

VERO Stock Summary

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 21.07%

Earnings are expected to fall -100% next year

Does not have any significance market cap ($11.64M)

Profit margins (-0.48%) are lower than the previous year (-0.44%)

VERO has less than 1 year of cash runway

Top 10 Correlated ETFs

VERO

Top 10 Correlated Stocks

VERO

In the News

10:07 29 May 2023 VERO

Venus Concept Inc. (VERO) Q1 2023 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q1 2023 Earnings Conference Call May 15, 2023 8:00 AM ET Company Participants Rajiv De Silva - CEO Hemanth Varghese - President & Chief Innovation and Business Officer Domenic Della Penna - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

07:30 29 May 2023 VERO

Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023

TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.

01:11 29 May 2023 VERO

Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

06:00 29 May 2023 VERO

Trading Penny Stocks? Top Technical Analysis Tips

Can this help you to make money with penny stocks? The post Trading Penny Stocks?

10:10 29 May 2023 VERO

Why Is Venus Concept (VERO) Stock Up 81% Today?

Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Wednesday following approval for its fractional skin resurfacing technology. The U.S. Food and Drug Administration (FDA) has signed off on the company's surgical robotic technology platform called AI.ME.

09:46 29 May 2023 VERO

Why Venus Concept (VERO) Shares Are Trading Higher Premarket Today? - Venus Concept (NASDAQ:VERO)

� 2022 Benzinga.com. Benzinga does not provide investment advice.

09:43 29 May 2023 VERO

Best Penny Stocks To Buy Now? 7 Insider Picks In November

7 penny stock picks from insiders in November 2022 The post Best Penny Stocks To Buy Now? 7 Insider Picks In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10:05 29 May 2023 VERO

Best Penny Stocks To Buy Now? 4 Insider Picks In November

Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?

02:47 29 May 2023 VERO

Activist Masters Capital Double Position in Venus Concept (VERO)

Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).

09:27 29 May 2023 VERO

Venus Concept Inc. (VERO) Q3 2022 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Marie Thibault - BTIG Anthony Vendetti - Maxim Group Operator Good day, ladies and gentlemen and welcome to the Third Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

VERO Financial details

Company Rating

Buy

Market Cap

11.64M

Income

-44.57M

Revenue

93.62M

Book val./share

-0.17

Cash/share

1.23

Dividend

Dividend %

Employees

384

Optionable

Shortable

Yes

Earnings

10 Aug 2023

P/E

-0.26

Forward P/E

PEG

-0.01

P/S

0.12

P/B

-12.84

P/C

1.85

P/FCF

-0.56

Quick Ratio

1.26

Current Ratio

2.15

Debt / Equity

-127.56

LT Debt / Equity

-83.53

EPS (TTM)

-2.36

EPS next Y

EPS next Q

EPS this Y

60.98%

EPS next Y

EPS next 5Y

EPS last 5Y

-44.82%

Revenue last 5Y

35.29%

Revenue Q/Q

-15.46%

EPS Q/Q

1214.29%

SMA20

-33.33%

SMA50

-33.33%

SMA100

-60%

Inst Own

61.35%

Inst Trans

-0.62%

ROA

-40%

ROE

-453%

ROC

-0.46%

Gross Margin

66%

Oper. Margin

-38%

Profit Margin

-48%

Payout

Shs Outstand

5.34M

Shs Float

2.32M

Target Price

5.5

52W Range

2.1011-12.0

52W High

-81%

52W Low

+14%

RSI

Rel Volume

0.99

Avg Volume

33.32K

Volume

32.92K

Perf Week

-2.98%

Perf Month

-20%

Perf Quarter

-45.5%

Perf Half Y

-30.53%

Beta

1.00121

Volatility

0.1%, 0.45%

Prev Close

-0%

Price

2.2799

Change

-5.79%

VERO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	9.83	194.45	31.95	1.94	1.51
Net income per share	-12.86	-74.49	-33.92	-0.41	-0.66
Operating cash flow per share	-12.85	-69.73	-11.73	-0.36	-0.41
Free cash flow per share	-13.3	-71.71	-11.85	-0.37	-0.41
Cash per share	7.22	27.59	14.05	0.57	0.18
Book value per share	0.71	130.64	18.12	0.75	0.12
Tangible book value per share	0.71	47.36	10.2	0.48	-0.05
Share holders equity per share	0.71	130.64	18.12	0.75	0.12
Interest debt per share	9.71	134.85	36.02	1.52	1.34
Market cap	219.17M	40.03M	63.36M	1.39B	316.61M
Enterprise value	222.52M	93.38M	108.67M	1.44B	388.81M
P/E ratio	-7.63	-0.95	-0.77	-62.73	-7.26
Price to sales ratio	9.98	0.36	0.81	13.15	3.18
POCF ratio	-7.64	-1.01	-2.21	-70.25	-11.73
PFCF ratio	-7.38	-0.98	-2.19	-68.48	-11.59
P/B Ratio	138.54	0.54	1.43	33.92	39.12
PTB ratio	138.54	0.54	1.43	33.92	39.12
EV to sales	10.13	0.85	1.39	13.59	3.91
Enterprise value over EBITDA	-8.68	-4.6	-2.69	-81.85	-12.78
EV to operating cash flow	-7.75	-2.36	-3.79	-72.63	-14.41
EV to free cash flow	-7.49	-2.29	-3.75	-70.79	-14.23
Earnings yield	-0.13	-1.06	-1.31	-0.02	-0.14
Free cash flow yield	-0.14	-1.02	-0.46	-0.01	-0.09
Debt to equity	18.58	1.54	2.64	2.74	14.41
Debt to assets	0.95	0.6	0.73	0.73	0.93
Net debt to EBITDA	-0.13	-2.63	-1.12	-2.68	-2.37
Current ratio	3.14	2.07	3.55	3.43	2.12
Interest coverage	-11.65	-2.69	-4.85	-3.54	-7.65
Income quality	1	0.94	0.35	0.89	0.62
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.4	0.43	0.74	0.43	0.5
Research and developement to revenue	0.38	0.07	0.1	0.08	0.11
Intangibles to total assets	0	0.26	0.12	0.1	0.1
Capex to operating cash flow	0.04	0.03	0.01	0.03	0.01
Capex to revenue	-0.05	-0.01	0	0	0
Capex to depreciation	-1.24	-0.55	-0.06	-0.11	-0.08
Stock based compensation to revenue	0.03	0.02	0.03	0.02	0.02
Graham number	14.31	467.93	117.58	2.62	1.35
ROIC	5.1	-0.14	-0.48	-0.19	-0.36
Return on tangible assets	-0.93	-0.3	-0.58	-0.16	-0.38
Graham Net	-2.5	-79.48	-13.93	-0.66	-0.99
Working capital	20.11M	51.53M	82.89M	75.78M	44.41M
Tangible asset value	1.58M	26.89M	24.9M	26.2M	-3.18M
Net current asset value	100K	-14.75M	-1.36M	-5.28M	-32.63M
Invested capital	12.31	0.93	1.8	1.9	10.35
Average receivables	5.22M	32.77M	55.87M	49.84M	42.09M
Average payables	2.93M	6.61M	7.86M	5.62M	6.47M
Average inventory	4.14M	12.18M	18.3M	19.15M	22.22M
Days sales outstanding	109.2	194.98	246.86	162.14	136.69
Days payables outstanding	111.85	101.66	86.67	56.88	87.46
Days of inventory on hand	161.89	203.78	243.48	237.83	260.27
Receivables turnover	3.34	1.87	1.48	2.25	2.67
Payables turnover	3.26	3.59	4.21	6.42	4.17
Inventory turnover	2.25	1.79	1.5	1.53	1.4
ROE	-18.16	-0.57	-1.87	-0.54	-5.39
Capex per share	-0.45	-1.98	-0.12	-0.01	-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric	2022-03-31	2022-06-30	2022-09-30	2022-12-31	2023-03-31
Revenue per share	0.41	0.43	0.33	0.34	3.93
Net income per share	-0.13	-0.16	-0.22	-0.14	-1.84
Operating cash flow per share	-0.19	-0.11	-0.06	-0.05	-1.13
Free cash flow per share	-0.2	-0.12	-0.06	-0.05	-1.14
Cash per share	0.28	0.16	0.1	0.16	1.23
Book value per share	0.51	0.36	0.14	0.11	-0.17
Tangible book value per share	0.3	0.15	-0.04	-0.05	-2.16
Share holders equity per share	0.51	0.36	0.14	0.11	-0.17
Interest debt per share	1.23	1.22	1.21	1.21	16.28
Market cap	1.37B	446.15M	430.68M	337.93M	17.16M
Enterprise value	1.43B	513.12M	501.52M	410.13M	94.18M
P/E ratio	-39.73	-10.61	-7.43	-8.5	-0.45
Price to sales ratio	51.98	16.36	20	13.91	0.84
POCF ratio	-110.48	-61.21	-111.58	-99.19	-2.91
PFCF ratio	-109.1	-60.43	-110.26	-98.07	-2.88
P/B Ratio	41.86	19.54	46.09	41.76	-19.36
PTB ratio	41.86	19.54	46.09	41.76	-19.36
EV to sales	54.24	18.82	23.28	16.89	4.59
Enterprise value over EBITDA	-226.07	-85.31	-48.48	-46.14	-13.18
EV to operating cash flow	-115.27	-70.4	-129.93	-120.38	-15.99
EV to free cash flow	-113.84	-69.5	-128.4	-119.02	-15.81
Earnings yield	-0.01	-0.02	-0.03	-0.03	-0.56
Free cash flow yield	-0.01	-0.02	-0.01	-0.01	-0.35
Debt to equity	3.39	4.79	11.84	14.41	-127.56
Debt to assets	0.77	0.82	0.92	0.93	1
Net debt to EBITDA	-9.41	-11.13	-6.85	-8.12	-10.77
Current ratio	3.33	3.14	2.74	2.12	2.15
Interest coverage	-8.06	-6.89	-9.37	-6.42	-5.41
Income quality	1.44	0.69	0.27	0.34	0.61
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.5	0.52	0.66	0.53	0.54
Research and developement to revenue	0.08	0.09	0.12	0.11	0.13
Intangibles to total assets	0.1	0.1	0.11	0.1	0.1
Capex to operating cash flow	0.01	0.01	0.01	0.01	0.01
Capex to revenue	-0.01	0	0	0	0
Capex to depreciation	-0.14	-0.08	-0.04	-0.03	-0.07
Stock based compensation to revenue	0.02	0.02	0.03	0.02	0.02
Graham number	1.25	1.15	0.85	0.6	2.65
ROIC	-0.07	-0.07	-0.11	-0.09	-0.09
Return on tangible assets	-0.07	-0.09	-0.13	-0.09	-0.09
Graham Net	-0.68	-0.79	-0.91	-0.93	-12.63
Working capital	68.83M	60.39M	51.25M	44.41M	41.54M
Tangible asset value	18.89M	9.73M	-2.78M	-3.18M	-11.27M
Net current asset value	-12.57M	-20.79M	-29.85M	-32.63M	-35.27M
Invested capital	2.36	3.39	8.31	10.35	-94.17
Average receivables	50.89M	50.86M	46.2M	40.04M	38.2M
Average payables	4.85M	4.49M	5.14M	7.06M	7.77M
Average inventory	20.93M	21.84M	23.3M	24.07M	23.29M
Days sales outstanding	177.66	163.67	178.87	138.09	171.61
Days payables outstanding	49.86	45.81	67.15	85.09	98.94
Days of inventory on hand	222	244.85	267.17	253.21	298.68
Receivables turnover	0.51	0.55	0.5	0.65	0.52
Payables turnover	1.81	1.96	1.34	1.06	0.91
Inventory turnover	0.41	0.37	0.34	0.36	0.3
ROE	-0.26	-0.46	-1.55	-1.23	10.86
Capex per share	0	0	0	0	-0.01

VERO Frequently Asked Questions

What is Venus Concept Inc. stock symbol ?

Venus Concept Inc. is a CA stock , located in Toronto of On and trading under the symbol VERO

What is Venus Concept Inc. stock quote today ?

Venus Concept Inc. stock price is $2.2799 today.

Is Venus Concept Inc. stock public?

Yes, Venus Concept Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 33.32K
Market Capitalization 11.64M
Employee 384
CEO Mr. Rajiv Kanishka Liyanaarchchie De Silva
Headquarters Toronto,ON,CA
IPO Date 2017-10-12
Website https://www.venusconcept.com

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.